Chemotherapy-induced cognitive impairment and glia: A new take on chemobrain?
Open Access
- 3 September 2024
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 492, 117085
Abstract
No abstract availableKeywords
Funding Information
- Applied Molecular Biosciences Unit (UI/BD/151318/2021)
- Fundação para a Ciência e a Tecnologia (LA/P/0140/2020, EXPL/MEDFAR/0203/2021, UIDP/04378/2020, UIDB/04378/2020)
This publication has 114 references indexed in Scilit:
- Inflammation as common link to progressive neurological diseasesArchives of Toxicology, 2023
- Lower myelin content is associated with more rapid cognitive decline among cognitively unimpaired individualsAlzheimer's & Dementia, 2023
- Chemobrain: mitoxantrone-induced oxidative stress, apoptotic and autophagic neuronal death in adult CD-1 miceArchives of Toxicology, 2022
- Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating eventsArchives of Toxicology, 2021
- Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFαCellular and Molecular Life Sciences, 2021
- The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy micePsychopharmacology, 2013
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Astrocyte control of the cerebrovasculatureGlia, 2007
- ‘Chemobrain’ in breast carcinoma?Cancer, 2004
- The psychological impact of cancer and cancer surgery.I. Adaptation to the dry colostomy; preliminary report and summary of findingsCancer, 1952